Therapeutic potential of the chemokine-receptor duo fractalkine/CX3CR1: an update.
about
CX3CR1 is a modifying gene of survival and progression in amyotrophic lateral sclerosisThe pain interactome: connecting pain-specific protein interactions.Cytosolic phospholipase A(2)α and eicosanoids regulate expression of genes in macrophages involved in host defense and inflammation.Placental fractalkine mediates adhesion of THP-1 monocytes to villous trophoblast.DNA Methylation Regulates the Differential Expression of CX3CR1 on Human IL-7Rαlow and IL-7Rαhigh Effector Memory CD8+ T Cells with Distinct Migratory Capacities to the FractalkineCX3CL1/CX3CR1-mediated microglia activation plays a detrimental role in ischemic mice brain via p38MAPK/PKC pathway.Plasma fractalkine is a sustained marker of disease severity and outcome in sepsis patients.Microglial aging in the healthy CNS: phenotypes, drivers, and rejuvenationFractalkine receptor is expressed in mature ovarian teratomas and required for epidermal lineage differentiation.Role of fractalkine/CX3CL1 and its receptor in the pathogenesis of inflammatory and malignant diseases with emphasis on B cell malignancies.Molecular mechanisms of actions of formulations of the thyroid hormone analogue, tetrac, on the inflammatory response.Targeting monocyte and macrophage subpopulations for immunotherapy: a patent review (2009 - 2013).Modulation of platelet and monocyte function by the chemokine fractalkine (CX3 CL1) in cardiovascular disease.AZD8797 is an allosteric non-competitive modulator of the human CX3CR1 receptor.A calpain inhibitor protects against fractalkine production in lipopolysaccharide-treated endothelial cellsFractalkine (CX3CL1) enhances hippocampal N-methyl-D-aspartate receptor (NMDAR) function via D-serine and adenosine receptor type A2 (A2AR) activity.Microglial phagocytosis and activation underlying photoreceptor degeneration is regulated by CX3CL1-CX3CR1 signaling in a mouse model of retinitis pigmentosa.Elucidation of Gene Expression Patterns in the Brain after Spinal Cord Injury.Functional analysis of the fractalkine gene promoter in human aortic smooth muscle cells exposed to proinflammatory conditions.Identifying a Novel Role for Fractalkine (CX3CL1) in Memory CD8 T Cell Accumulation in the Omentum of Obesity-Associated Cancer Patients
P2860
Q21132045-A2FA7384-A7EF-47CF-AF9F-8EBC3B914D6DQ34585717-2B3573A8-B332-45BD-83D2-7849FF450A20Q34945785-2A7A51FC-6E24-4624-A010-1563456A1822Q35804672-E77AD7D1-EE4F-4442-B5CA-5F2EEC9B70A6Q36031603-21B6DF2E-1CC0-4B1C-92CC-696C183910FAQ36267362-D3CC4531-7B36-49D6-AC76-0F9885E6B92CQ36317219-789E9A3D-65DB-4E9D-B322-8DD5E5659393Q36678453-A5A8252B-2A27-4897-A24B-5B2A813C14C9Q37116062-C8FECC19-61AD-460C-8EB5-CFC16972F5D9Q37700771-3D329B42-5BDD-48AD-BCE7-4F2B853BDEF3Q38094799-0F481D25-2FEE-4CFE-B33B-E1B363352169Q38207732-8C9E35A4-2AAF-433C-B3A9-8C031E949319Q38400503-89F8755D-CD61-448B-B94A-2C498AEBD721Q38608720-0775791A-1C46-4F5F-9DC8-F6679BD54EBDQ41387361-295CDA5E-D14A-45C1-AD4C-6BE95EAA35ADQ42117984-8E64FEEC-3FB7-452B-8860-EA4CF175AF44Q42174317-09642330-20D0-41F3-840D-8D2415BC6BC5Q47140191-A75D64E7-CAE3-435F-9851-CBBADD644AF4Q54336718-0D879D3B-51E0-442E-B089-D3778244C846Q58785715-1917762D-ED2A-49A4-828E-9E83063C2EA5
P2860
Therapeutic potential of the chemokine-receptor duo fractalkine/CX3CR1: an update.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Therapeutic potential of the chemokine-receptor duo fractalkine/CX3CR1: an update.
@en
type
label
Therapeutic potential of the chemokine-receptor duo fractalkine/CX3CR1: an update.
@en
prefLabel
Therapeutic potential of the chemokine-receptor duo fractalkine/CX3CR1: an update.
@en
P2860
P1476
Therapeutic potential of the chemokine-receptor duo fractalkine/CX3CR1: an update.
@en
P2093
Jan G D'Haese
P2860
P304
P356
10.1517/14728222.2012.682574
P407
P577
2012-04-25T00:00:00Z